--- title: | Croom Lawrence description: As Chief Commercial Officer of Hemostemix, I am leading commercialization and patient services for our pioneering autologous stem cell therapy, ACP-01, to restore health for patients with cardiovascular, dermatological, and neurological diseases. We are disrupting the standard of care for ischemic disease, from heart failure to wound care to vascular dementia, by providing a science-backed, personalized cellular therapy for those with limited or no other options. My mission is to ensure these life-changing treatments reach the individuals who need them most. --- [![VesCell Logo smaller 080125](https://www.vescell.health/hubfs/VesCell%20Logo%20smaller%20080125.png)](https://www.vescell.health) ![menu](https://f.hubspotusercontent40.net/hubfs/7479797/menu.png) ![close_24px](https://7479797.fs1.hubspotusercontent-na1.net/hubfs/7479797/close_24px.svg) - [Story](https://www.vescell.health/our-story) - [Memberships](https://www.vescell.health/memberships) - [Events](https://www.vescell.health/events) - [Registry](https://www.vescell.health/registry) - GLOBAL - [Story](https://www.vescell.health/our-story) - [Memberships](https://www.vescell.health/memberships) - [Events](https://www.vescell.health/events) - [Registry](https://www.vescell.health/registry) - GLOBAL [Request Appointment](https://calendly.com/clawrence-hemostemix) ![](https://www.vescell.health/hubfs/Croom%20Lawrene%20Bio%20Pic.jpg) ### Croom Lawrence As Chief Commercial Officer of Hemostemix, I am leading commercialization and patient services for our pioneering autologous stem cell therapy, ACP-01, to restore health for patients with cardiovascular, dermatological, and neurological diseases. We are disrupting the standard of care for ischemic disease, from heart failure to wound care to vascular dementia, by providing a science-backed, personalized cellular therapy for those with limited or no other options. My mission is to ensure these life-changing treatments reach the individuals who need them most. All Post - [All Post](https://www.vescell.health/hemostemix-blog) - [Chronic Limb Threatening Ischemia](https://www.vescell.health/hemostemix-blog/tag/chronic-limb-threatening-ischemia) - [Heart Failure](https://www.vescell.health/hemostemix-blog/tag/heart-failure) - [Wound Care](https://www.vescell.health/hemostemix-blog/tag/wound-care) Search ###### Topics - [Chronic Limb Threatening Ischemia](https://www.vescell.health/hemostemix-blog/tag/chronic-limb-threatening-ischemia) - [Heart Failure](https://www.vescell.health/hemostemix-blog/tag/heart-failure) - [Wound Care](https://www.vescell.health/hemostemix-blog/tag/wound-care) ###### Popular Post - [New Hope for Heart Health](https://www.vescell.health/hemostemix-blog/new-hope-for-heart-health) - [Revolutionizing CLI Treatment: Insights from VesCell HealthTalks #10](https://www.vescell.health/hemostemix-blog/revolutionizing-cli-treatment-insights-from-vescell-healthtalks-10) ###### Subscribe [![Revolutionizing CLI Treatment: Insights from VesCell HealthTalks #10](https://www.vescell.health/hs-fs/hubfs/Foot%20with%20CLI.png?width=400&upsize=true&name=Foot%20with%20CLI.png)](https://www.vescell.health/hemostemix-blog/revolutionizing-cli-treatment-insights-from-vescell-healthtalks-10) [Chronic Limb Threatening Ischemia](https://www.vescell.health/hemostemix-blog/tag/chronic-limb-threatening-ischemia) [Wound Care](https://www.vescell.health/hemostemix-blog/tag/wound-care) ###### [Revolutionizing CLI Treatment: Insights from VesCell HealthTalks #10](https://www.vescell.health/hemostemix-blog/revolutionizing-cli-treatment-insights-from-vescell-healthtalks-10) On September 11, 2025, Hemostemix hosted its 10th VesCell HealthTalks webinar, led by Chief... 7 minute read ![Croom Lawrence](https://www.vescell.health/hubfs/Croom%20Lawrene%20Bio%20Pic.jpg) [Croom Lawrence](https://www.vescell.health/hemostemix-blog/author/croom-lawrence) 11 September 2025 [Read More](https://www.vescell.health/hemostemix-blog/revolutionizing-cli-treatment-insights-from-vescell-healthtalks-10) [![New Hope for Heart Health](https://www.vescell.health/hs-fs/hubfs/Heart%20AI.png?width=400&upsize=true&name=Heart%20AI.png)](https://www.vescell.health/hemostemix-blog/new-hope-for-heart-health) [Heart Failure](https://www.vescell.health/hemostemix-blog/tag/heart-failure) ###### [New Hope for Heart Health](https://www.vescell.health/hemostemix-blog/new-hope-for-heart-health) ## Exploring ACP-01 and the Future of Heart Failure ❤️ Cardiovascular disease remains a leading... 4 minute read ![Croom Lawrence](https://www.vescell.health/hubfs/Croom%20Lawrene%20Bio%20Pic.jpg) [Croom Lawrence](https://www.vescell.health/hemostemix-blog/author/croom-lawrence) 5 September 2025 [Read More](https://www.vescell.health/hemostemix-blog/new-hope-for-heart-health) [![VesCell Logo White](https://www.vescell.health/hubfs/VesCell%20Logo%20White.png)](https://makewebbetter-7479797.hs-sites.com/en/austin) VesCell (ACP-01) is an investigational therapy under development and not approved by the FDA. VesCell is available through special access programs that may be approved on a case-by-case basis in Canada, Bahamas and Domican Republic for treatment of no option patients suffering from CLTI, no option patients suffering from chronic stable angina, no option ischemic and non-ischemic dilated cardiomyopathy. - - - - - ###### Resources - [Story](https://www.vescell.health/our-story) - [Memberships](https://www.vescell.health/memberships) - [Events](https://www.vescell.health/events) - [Registry](https://www.vescell.health/registry) - GLOBAL ###### We're here to help 1-239-522-2906 [Customer Success: clawrence@hemostemix.com](mailto:clawrence@hemostemix.com)   Corporate Office: tsmeenk@hemostemix.com 707 7 Ave SW #1150 Calgary, AB T2P 3H6 © 2025 Hemostemix Inc. All Rights reserved. [Privacy Policy |](https://www.vescell.health/hubfs/Hemostemix_Privacy%20Notice_2025.docx) [Terms & Condition](http://www.hubspot.com)